Chimeric Therapeutics is the ASX leader in cell therapy. As the only clinical stage, cell therapy biotechnology company in Australia, our focus is on discovering, developing and commercialising novel cell therapies with the most potential for patients. ASX: CHM
| Website | http://www.chimerictherapeutics.com |
| Employees | 7 (5 on RocketReach) |
| Founded | 2020 |
| Address | 62 Lygon St, LEVEL 3, Carlton, Victoria 3053, AU |
| Industry | Biotechnology Research |
| Keywords | Cell Therapy, Cell Therapies, Biotechnology, Biotech, Asx Listed, Biopharma, Life Sciences, Clinical Stage, Novel Therapies, Immunotherapy, Drug Development, Therapeutic Discovery, Cancer Treatment, Clinical Trials, Oncology, Regenerative Medicine, Pharmaceutical, Patient Care, Healthcare, Medicine |
| Competitors | Celyad Oncology, Zymeworks Inc., TCR² Therapeutics Inc., Adaptimmune, Allogene Therapeutics, bluebird bio, Intellia Therapeutics, Inc., Novartis, Gilead Sciences, Cellectis +42 more (view full list) |
Looking for a particular Chimeric Therapeutics employee's phone or email?
Chimeric Therapeutics Questions
Rebecca McQualter is the Chief Executive Officer and Managing Director of Chimeric Therapeutics.
5 people are employed at Chimeric Therapeutics.
Chimeric Therapeutics is based in Carlton, Victoria.
Top Chimeric Therapeutics Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
